Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human ETFDH Antikörper:
anti-Mouse (Murine) ETFDH Antikörper:
anti-Rat (Rattus) ETFDH Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal ETFDH Primary Antibody für ELISA, WB - ABIN4309655
Illig, Gieger, Zhai, Römisch-Margl, Wang-Sattler, Prehn, Altmaier, Kastenmüller, Kato, Mewes, Meitinger, de Angelis, Kronenberg, Soranzo, Wichmann, Spector, Adamski, Suhre: A genome-wide perspective of genetic variation in human metabolism. in Nature genetics 2010
Neurite shortening and impairment in neurite growth was caused by a mutation in ETFDH.
This study identified three novel compound heterozygous mutations of ETFDH gene in patients with late-onset multiple acyl-CoA dehydrogenase (zeige ACADM Antikörper) deficiency, and discussed the significant clinical heterogeneity among patients with similar genotype.
ETFDH mutation is the causative gene in patients with adult-onset multiple acyl-CoA dehydrogenase (zeige ACADM Antikörper) deficiency with severe sensory neuropathy.
Mtation c.250G>A and mutation c.353G>T in the ETFDH gene are associate with multiple aeyl-CoA dehydrogenase deficiency with severe fatty liver.
identified 61 ETFDH mutations, including 31 novel mutations, which were widely distributed within the coding sequence
Mutations in SLC22A5 (zeige SLC22A5 Antikörper) and ETFDH are associated with riboflavin responsive-multiple acyl-CoA dehydrogenase (zeige ACADM Antikörper) deficiency.
Results show that a predicted benign ETFDH missense variationc.158A>G in exon 2 causes exon skipping and degradation of ETFDH protein in patient samples.
Case Report: ETF dehydrogenase mutations resulting in mild glutaric aciduria type II and complex II-III deficiency in liver and muscle.
folding defects in the variant ETF-QO proteins and multiple acyl-CoA (zeige GNPAT Antikörper) dehydrogenation deficiency
a significant reduced expression of ETFDH was identified in the muscle of ETFDH-deficient patients; ETFDH deficiency is a major cause of riboflavin-responsive MADD (zeige ETFA Antikörper) in southern China, and c.250G>A is an important mutation
Data indicate that the iron-sulfur cluster of electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) is the electron acceptor for electron transfer flavoprotein (zeige ETFB Antikörper).
Studies indicate that ETF-QO to be a monotopic membrane protein with the cofactors, FAD (zeige PSEN1 Antikörper) and a [4Fe-4S](+1+2) cluster, suggesting that it is the flavin that serves as the immediate reductant of ubiquinone.
Electron-transferring-flavoprotein dehydrogenase in the inner mitochondrial membrane accepts electrons from electron-transfer flavoprotein which is located in the mitochondrial matrix and reduces ubiquinone in the mitochondrial membrane. The protein is synthesized as a 67-kDa precursor which is targeted to mitochondria and processed in a single step to a 64-kDa mature form located in the mitochondrial membrane. Deficiency in electron-transferring-flavoprotein dehydrogenase have been demonstrated in some patients with type II glutaricacidemia.
, ETF-ubiquinone oxidoreductase
, electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial
, electron-transferring-flavoprotein dehydrogenase
, electron transferring flavoprotein dehydrogenase
, Electron-transferring-flavoprotein dehydrogenase
, Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial
, LOW QUALITY PROTEIN: electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial